An evidence-based, side-by-side comparison of two research compounds — mechanisms, studies, and clinical status.
GnRH Modulator
GH Secretagogue Blend
| Property | Kisspeptin-10 | CJC-1295/Ipamorelin |
|---|---|---|
| Category | GnRH Modulator | GH Secretagogue Blend |
| Formula | C63H83N17O14 | Blend |
| Molecular Weight | 1,302.44 g/mol | Blend |
| Published Studies | 200+ | 35+ |
| Clinical Status | Clinical Trials Ongoing | Preclinical Research |
| Overview | A 10-amino-acid neuropeptide that controls GnRH neuron activation and the HPG axis. | CJC-1295 No DAC + Ipamorelin blend for synergistic GH secretagogue research. |
Kisspeptin-10 is the active fragment of the kisspeptin family, encoded by the KISS1 gene. Master regulator of reproductive hormone signaling.
Directly activates GnRH neurons, triggering LH and FSH release. Without it, reproductive function ceases.
Used in multiple human clinical trials at Imperial College London.
Combines CJC-1295 No DAC (GHRH analog) and Ipamorelin (ghrelin receptor agonist) for dual-pathway GH release.
CJC-1295 primes via GHRH receptors. Ipamorelin activates ghrelin receptors. Together they amplify GH secretion.
Educational content for informational purposes only. Not medical advice.